RPS28: A Potential Drug Target and Biomarker for Small Ribosomal Subunit Protein eS28

Target Name: RPS28

NCBI ID: G6234

RPS28

RPS28: A Potential Drug Target and Biomarker for Small Ribosomal Subunit Protein eS28

Small Ribosomal Subunit Protein (SRSP) eS28 is a key protein that plays a crucial role in the regulation of gene expression and cell signaling. It is a highly conserved protein that can be found in various cell types, including bacteria, archaea, and eukaryotes. RPS28 has been shown to play a significant role in various cellular processes, including DNA replication, transcription, and translation.

Recent studies have identified potential drug targets and biomarkers for RPS28. In this article, we will discuss the research on RPS28 and its potential as a drug target and biomarker.

Potential Drug Targets

RPS28 has been identified as a potential drug target due to its unique structure and various cellular processes. RPS28 is a 28 kDa protein that contains a single gene. It consists of a 166 amino acid chain with a calculated pI of 11.9. RPS28 is highly conserved and has a low sequence identity, which suggests that it has a unique mechanism of stability.

One potential mechanism for RPS28 as a drug target is its role in cell signaling. RPS28 has been shown to play a significant role in regulating gene expression and cell signaling. It has been shown to interact with various cellular signaling pathways, including the DNA replication, transcription, and translation pathways.

In addition, RPS28 has been shown to play a role in the regulation of cellular processes that are important for cancer progression. For example, RPS28 has been shown to be involved in the regulation of cell cycle progression, apoptosis, and angiogenesis. These processes are critical for the development and progression of cancer, and targeting RPS28 may be a potential strategy for cancer treatment.

Potential Biomarkers

RPS28 has also been identified as a potential biomarker for various diseases. One of the main advantages of RPS28 as a biomarker is its stability and expression. RPS28 is a highly conserved protein that is expressed in various cell types, making it a potential biomarker for diseases.

In addition, RPS28 has been shown to play a role in the regulation of cellular processes that are important for disease progression. For example, RPS28 has been shown to play a role in the regulation of cancer cell growth, angiogenesis, and metastasis. These processes are critical for the development and progression of diseases, and targeting RPS28 may be a potential strategy for disease treatment.

Conclusion

RPS28 is a protein that has significant involvement in various cellular processes, including gene expression, cell signaling, and disease progression. Its unique structure and conservation make it a potential drug target and biomarker. Further research is needed to fully understand the role of RPS28 in cellular processes and its potential as a drug target and biomarker.

Protein Name: Ribosomal Protein S28

Functions: Component of the small ribosomal subunit (PubMed:23636399, PubMed:25901680, PubMed:25957688). The ribosome is a large ribonucleoprotein complex responsible for the synthesis of proteins in the cell (PubMed:23636399, PubMed:25901680, PubMed:25957688). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome (PubMed:34516797)

The "RPS28 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPS28 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets